Payment overview · 2025
General Payments
$19.84
1 reported records · 1 companies
Healthcare provider profile · identity verified
Yanitza Rodriguez, M.D
Allopathic & Osteopathic Physicians|Internal Medicine · BOYNTON BEACH, FL · NPI 1356515019
Verified facts
What the public records show
CMS Open Payments records show Yanitza Rodriguez, M.D received $19.84 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 120 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 39 claims for Lokelma by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $19.84 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.84 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $19.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 120 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
120 | 24 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
39 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1088 | 263 |
| Levothyroxine Sodium | Levothyroxine Sodium | 799 | 175 |
| Amlodipine Besylate | Amlodipine Besylate | 790 | 175 |
| Pantoprazole Sodium | Pantoprazole Sodium | 606 | 168 |
| Eliquis | Apixaban | 578 | 98 |
| Furosemide | Furosemide | 567 | 142 |
| Losartan Potassium | Losartan Potassium | 490 | 121 |
| Gabapentin | Gabapentin | 481 | 123 |
| Lisinopril | Lisinopril | 462 | 108 |
| Potassium Chloride | Potassium Chloride | 439 | 110 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 412 | 119 |
| Metformin Hcl | Metformin Hcl | 367 | 92 |
| Tamsulosin Hcl | Tamsulosin Hcl | 347 | 93 |
| Trazodone Hcl | Trazodone Hcl | 340 | 99 |
| Mirtazapine | Mirtazapine | 329 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 325 | 81 |
| Carvedilol | Carvedilol | 279 | 68 |
| Famotidine | Famotidine | 275 | 86 |
| Escitalopram Oxalate | Escitalopram Oxalate | 269 | 78 |
| Sertraline Hcl | Sertraline Hcl | 250 | 71 |
| Metoprolol Tartrate | Metoprolol Tartrate | 248 | 65 |
| Omeprazole | Omeprazole | 213 | 51 |
| Duloxetine Hcl | Duloxetine Hcl | 208 | 43 |
| Donepezil Hcl | Donepezil Hcl | 202 | 56 |
| Hydralazine Hcl | Hydralazine Hcl | 190 | 47 |
| Clopidogrel | Clopidogrel Bisulfate | 182 | 50 |
| Levetiracetam | Levetiracetam | 164 | 34 |
| Memantine Hcl | Memantine Hcl | 156 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 151 | 46 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 148 | 90 |
| Quetiapine Fumarate | Quetiapine Fumarate | 148 | 49 |
| Alprazolam | Alprazolam | 141 | 39 |
| Clonazepam | Clonazepam | 136 | 26 |
| Ondansetron Hcl | Ondansetron Hcl | 131 | 62 |
| Azithromycin | Azithromycin | 130 | 93 |
| Farxiga | Dapagliflozin Propanediol | 120 | 24 |
| Simvastatin | Simvastatin | 115 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 114 | 41 |
| Pravastatin Sodium | Pravastatin Sodium | 108 | 28 |
| Bumetanide | Bumetanide | 104 | 25 |
| Montelukast Sodium | Montelukast Sodium | 96 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 95 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 93 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 92 | 19 |
| Celecoxib | Celecoxib | 91 | 30 |
| Latanoprost | Latanoprost | 91 | 27 |
| Temazepam | Temazepam | 91 | 26 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 89 | 47 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 88 | 77 |
| Xarelto | Rivaroxaban | 88 | 28 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 87 | 31 |
| Allopurinol | Allopurinol | 85 | 25 |
| Divalproex Sodium | Divalproex Sodium | 84 | 29 |
| Novolog Flexpen | Insulin Aspart | 83 | 16 |
| Prednisone | Prednisone | 83 | 22 |
| Valsartan | Valsartan | 83 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 79 | 53 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 78 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 78 | 23 |
| Lactulose | Lactulose | 78 | 24 |
| Nifedipine Er | Nifedipine | 78 | 25 |
| Spironolactone | Spironolactone | 78 | 23 |
| Ezetimibe | Ezetimibe | 77 | 27 |
| Glipizide Er | Glipizide | 76 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 75 | 39 |
| Metformin Hcl Er | Metformin Hcl | 75 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 74 | 22 |
| Buspirone Hcl | Buspirone Hcl | 74 | 19 |
| Jardiance | Empagliflozin | 73 | 18 |
| Midodrine Hcl | Midodrine Hcl | 72 | 28 |
| Ozempic | Semaglutide | 72 | 17 |
| Fenofibrate | Fenofibrate Nanocrystallized | 71 | 13 |
| Warfarin Sodium | Warfarin Sodium | 70 | suppressed |
| Risperidone | Risperidone | 69 | 19 |
| Tramadol Hcl | Tramadol Hcl | 68 | 37 |
| Glipizide | Glipizide | 67 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 67 | 13 |
| Alendronate Sodium | Alendronate Sodium | 66 | 20 |
| Cephalexin | Cephalexin | 66 | 49 |
| Diclofenac Sodium | Diclofenac Sodium | 65 | 27 |
| Finasteride | Finasteride | 65 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 65 | 23 |
| Baclofen | Baclofen | 64 | 20 |
| Lorazepam | Lorazepam | 62 | 16 |
| Mupirocin | Mupirocin | 62 | 31 |
| Methylprednisolone | Methylprednisolone | 61 | 38 |
| Atenolol | Atenolol | 60 | 19 |
| Liothyronine Sodium | Liothyronine Sodium | 60 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 59 | 25 |
| Pregabalin | Pregabalin | 58 | 17 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 55 | 25 |
| Hydrocortisone | Hydrocortisone | 52 | 20 |
| Entresto | Sacubitril/Valsartan | 51 | 12 |
| Propranolol Hcl | Propranolol Hcl | 51 | 15 |
| Sodium Chloride | 0.9 % Sodium Chloride | 50 | 22 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 49 | 16 |
| Nystatin | Nystatin | 49 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | suppressed |
| Meloxicam | Meloxicam | 48 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 48 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 47 | 14 |
| Bupropion Xl | Bupropion Hcl | 45 | 18 |
| Clonidine Hcl | Clonidine Hcl | 44 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 43 | 20 |
| Clobetasol Propionate | Clobetasol Propionate | 42 | 15 |
| Humulin R | Insulin Regular, Human | 41 | suppressed |
| Mounjaro | Tirzepatide | 41 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 40 | 12 |
| Labetalol Hcl | Labetalol Hcl | 40 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 40 | 40 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 40 | suppressed |
| Glucagon Emergency Kit | Glucagon | 39 | 23 |
| Lokelma | Sodium Zirconium Cyclosilicate | 39 | suppressed |
| Movantik | Naloxegol Oxalate | 39 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 37 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 37 | 25 |
| Myrbetriq | Mirabegron | 37 | suppressed |
| Trulicity | Dulaglutide | 37 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 36 | 14 |
| Ketoconazole | Ketoconazole | 36 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 35 | 13 |
| Aripiprazole | Aripiprazole | 34 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 34 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 33 | suppressed |
| Glimepiride | Glimepiride | 33 | 11 |
| Ibuprofen | Ibuprofen | 32 | 17 |
| Ipratropium Bromide | Ipratropium Bromide | 32 | 12 |
| Torsemide | Torsemide | 32 | suppressed |
| Calcium Acetate | Calcium Acetate | 30 | suppressed |
| Estradiol | Estradiol | 30 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | 13 |
| Dextrose In Water | Dextrose 5 % In Water | 29 | 11 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 29 | suppressed |
| Lidocaine | Lidocaine | 29 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 29 | 16 |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 28 | 11 |
| Diazepam | Diazepam | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 26 | 18 |
| Rezvoglar Kwikpen | Insulin Glargine-Aglr | 26 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 26 | 11 |
| Albuterol Sulfate | Albuterol Sulfate | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Budesonide | Budesonide | 25 | suppressed |
| Ertapenem | Ertapenem Sodium | 25 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | 12 |
| Procrit | Epoetin Alfa | 24 | suppressed |
| Ranolazine Er | Ranolazine | 24 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Folic Acid | Folic Acid | 23 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 23 | suppressed |
| Olanzapine | Olanzapine | 23 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 22 | suppressed |
| Fluconazole | Fluconazole | 22 | 19 |
| Insulin Lispro | Insulin Lispro | 22 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 22 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 22 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 22 | suppressed |
| Amantadine | Amantadine Hcl | 21 | suppressed |
| Clotrimazole | Clotrimazole | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | 11 |
| Ibandronate Sodium | Ibandronate Sodium | 21 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 21 | 18 |
| Ursodiol | Ursodiol | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Gemtesa | Vibegron | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 14 |
| Dapagliflozin | Dapagliflozin Propanediol | 18 | 13 |
| Enoxaparin Sodium | Enoxaparin Sodium | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 16 |
| Ziprasidone Hcl | Ziprasidone Hcl | 18 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 17 | suppressed |
| Levofloxacin | Levofloxacin | 17 | 13 |
| Telmisartan | Telmisartan | 17 | suppressed |
| Topiramate | Topiramate | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Methimazole | Methimazole | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 15 | suppressed |
| Zonisamide | Zonisamide | 15 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 14 | suppressed |
| Cyclosporine | Cyclosporine | 14 | suppressed |
| Daptomycin | Daptomycin | 14 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Novolin R | Insulin Regular, Human | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Ceftriaxone | Ceftriaxone In Is-Osm Dextrose | 13 | suppressed |
| Exemestane | Exemestane | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Mesalamine Er | Mesalamine | 13 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 13 | suppressed |
| Abilify Maintena | Aripiprazole | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Fluocinolone Acetonide | Fluocinolone Acetonide | 11 | suppressed |
| Ingrezza | Valbenazine Tosylate | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Olopatadine Hcl | Olopatadine Hcl | 11 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.84 · 1 records | AstraZeneca Pharmaceuticals LP | FARXIGA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error